ABSTRACT In order to improve genotyping and epidemiological analysis of Cryptosporidium spp., genomic data need to be generated directly from a broad range of clinical specimens. Utilizing a robust method that we developed for the purification and generation of amplified target DNA, we present its application for the successful isolation and whole-genome sequencing of 14 different Cryptosporidium hominis patient specimens. Six isolates of subtype IbA10G2 were analyzed together with a single representative each of 8 other subtypes: IaA20R3, IaA23R3, IbA9G3, IbA13G3, IdA14, IeA11G3T3, IfA12G1, and IkA18G1. Parasite burden was measured over a range of more than 2 orders of magnitude for all samples, while the genomes were sequenced to mean depths of between 17ϫ and 490ϫ coverage. Sequence homologybased functional annotation identified several genes of interest, including the gene encoding Cryptosporidium oocyst wall protein 9 (COWP9), which presented a predicted loss-of-function mutation in all the sequence subtypes, except for that seen with IbA10G2, which has a sequence identical to the Cryptosporidium parvum reference Iowa II sequence. Furthermore, phylogenetic analysis showed that all the IbA10G2 genomes form a monophyletic clade in the C. hominis tree as expected and yet display some heterogeneity within the IbA10G2 subtype. The current report validates the aforementioned method for isolating and sequencing Cryptosporidium directly from clinical stool samples. In addition, the analysis demonstrates the potential in mining data generated from sequencing multiple whole genomes of Cryptosporidium from human fecal samples, while alluding to the potential for a higher degree of genotyping within Cryptosporidium epidemiology.
C
ryptosporidium species are protozoan parasites and leading causative agents of severe diarrhea worldwide, responsible for increasing morbidity and mortality in parts of Asia and Africa among children under 5 years old (1) . While 29 species have currently been identified, Cryptosporidium parvum and C. hominis are the species responsible for the vast majority of all human cases (2) . Cryptosporidium spp. are often further genotyped into subtypes using sequence analysis of the hypervariable 60-kDa glycoprotein (gp60) gene (3) . Within C. hominis, the IbA10G2 subtype has been commonly associated with major outbreaks in industrialized nations (4) (5) (6) and has recently been identified as the genotype most likely to have undergone genetic recombination (7) . Some studies suggest that such diversity may be linked to the polymorphic nature of telomeric regions (8, 9) . Indeed, there are limitations to the genotyping resolution of gp60 that have led to multiple studies looking into the potential use of multilocus sequence typing (MLST) in order to infer the population structures of Cryptosporidium (10) (11) (12) without generating any consensus list of genetic markers. The advent of next-generation sequencing (NGS) has led to an immense interest in public health pathogen genome sequencing (13, 14) as an alternative to MLST. Despite the generation of several complete genomes, including those of C. parvum (15) and C. hominis (16, 17) , the lack of long-term culturing capabilities and the general dearth of sufficient clinical material have made it difficult to extract enough target-specific DNA for sequencing Cryptosporidium genomes on a routine basis.
Recently, several studies have aimed to develop methods to purify and overcome the limitation of low quantities of target material in order to enable whole-genome sequencing of Cryptosporidium directly from fecal specimens (18) (19) (20) (21) . This has involved removing as much of the contaminating material and microbe population as possible, thereby improving the target-specific enrichment (immunomagnetic separation [IMS] , flotation, bleaching) as well as increasing the quantity of Cryptosporidium DNA available for sequencing (whole-genome amplification kits, PCR amplification) and the use of different sequencing platforms and analysis pipelines.
Previously, we presented a proof-of-principle method to generate target-enriched oocysts via IMS, minimizing carryover of contaminants and loss of parasite material, and a library PCR amplification step which generates uniform coverage following wholegenome sequencing on the Ion Torrent platform from clinical material (18) . Utilizing this method, here we present 14 C. hominis genomes that were sequenced from patient stool samples, including six subtype IbA10G2 isolates. Furthermore, we provide a preliminary analysis of the data set, demonstrating the divergence of the IbA10G2 subtype from all the other sequenced C. hominis isolates in this study. The wealth of genome data generated allows us to speculate how mining such information could improve the genotype resolution of Cryptosporidium species and subtypes.
RESULTS
Assessment of sample purity and data quality. The samples contained 0.07 ϫ 10 5 to 9.9 ϫ 10 5 parasites after the purification protocol. Apart from our C. hominis reference genome (SWEH1) and SWEH10, the amount of DNA of all the other samples was below the limit of detection (LOD) using Qubit fluorometric quantification (Table  1) . In addition, due to the various parasite burdens and levels of background DNA, the concentration of the amplified sequencing libraries ranged from 12 to 3,500 pM (data not shown). After sequencing, on average, 79% (range, 48% to 96%) of the sequences mapped to the C. hominis TU502 reference genome, while the fraction of the reference genome covered was over 90% for the vast majority of samples and was at least 99% for half of the samples. Genome sequence coverage for SWEH2 to SWEH13 ranged between mean depths of 17ϫ and 62ϫ (Table 1) . Annotation of the C. hominis genome and generation of a IbA10G2 reference. The previously published SWEH1 assembly (18) was further refined for this paper by optimizing assembly settings and a new genome finishing method but by using the same general workflow as described in the previous paper (data not shown). This resulted in an assembled genome consisting of 13 contigs with a total length of 9,040,288 bp and an N50 of 1,060,481 bp.
To improve the usefulness of this assembly, it was annotated using BLAST and the BLAST2GO annotation pipeline (default settings). First, 3,673 of 3,887 gene annotations were successfully transferred to the SWEH1 genome from C. parvum Iowa II using a BLASTn E value cutoff of 10eϪ3 in the CLC Genome Finishing module. Furthermore, gene annotations where sequence homology was low but protein conservation was high were identified by annotating all open reading frames (ORFs) within the SWEH1 genome and then filtering away already transferred annotations. This generated a set of 239 ORFs that did not overlap any already-transferred annotations from C. parvum Iowa II. These ORFs were matched to the NCBI nonredundant protein database using BLASTx. Of the 239 nontransferred ORFs, 229 were confirmed as being Cryptosporidiumspecific genes matching entries from C. parvum Iowa II, C. hominis TU502, or C. muris RN66 in the NCBI nonredundant protein database. Three ORFs had annotations originating from Butyrivibrio crossotus, and 7 ORFs lacked BLASTx hits altogether (Fig. 1 ). These were annotated as "SWEH1 unknown protein. " In total, 3,912 genes (3,673 transferred annotations and 239 new ORFs) were evaluated with BLAST2GO, and, of these, 2,188 were successfully mapped to a GO-Slim annotation. An additional 1,643 had BLASTx hits but no relevant annotations, and 81 genes lacked BLAST hits (Fig. 2) . However, 67 of these genes were shorter than 130 bp, making them unlikely gene candidates for functional proteins. Of the remaining 14 ORFs without a BLASTx hit in the NCBI-nr database, 7 represented genes encoding the "SWEH1 hypothetical proteins" and one Cryptosporidium gene (cgd7_1280). Six SWEH1 hypothetical proteins and the protein encoded by cgd7_1280 had several InterProScan (IPS) hits indicating functional domains. After annotation of the SWEH1 genome, the raw data from the IbA10G2 samples (SWEH8 to SWEH13) was mapped against the SWEH1 reference and a consensus sequence was generated representing a IbA10G2 pan-genome. Conflicting bases were resolved using a majority-vote rule. The annotations from SWEH1 were then transferred to the new reference. Among all the annotations, 25 failed to transfer due to low overlap or no intersection with the IbA10G2 reference sequence. The estimated exome length was calculated using the sum of all gene annotations, corresponding to 6,814,123 bp, and the genome length was estimated to total 9,038,021 bp. Thus, the coding region of the IbA10G2 pan-genome constitutes 75.3% of the genome size, showing good correlation to the corresponding figure for the C. parvum Iowa II genome (74.9%). The annotated genome was then used as a reference for variant calling and genomic analysis.
Sequence homology-guided prediction of function. Sequence homologies and functional prediction were investigated using three complementary approaches. First, a possible gain of function was investigated by identifying ORFs present in the pan-IbA10G2 reference but missing from the SWEH1 reference. Second, loss of function from a single event was investigated by identifying conserved variants causing nonsynonymous substitutions in all non-IbA10G2 subtypes followed by filtering by gene name, gene ontology, and the predicted impact of the change. Third, losses of function resulting from multiple nonlinked events were investigated by identifying all genes that contained one or more nonsynonymous substitutions in all subtypes except IbA10G2 and filtering by impact; genes with a predicted nonsynonymous substitution in all subtypes were then obtained.
Genes that might be subtype specific were identified in IbA10G2 by their ORFs and filtered against the existing set of SWEH1 genes and ORFs. This resulted in the identification of 65 additional ORFs that did not overlap previously transferred annotations from SWEH1 using a threshold E value of 10eϪ3. To distinguish between annotations that had not been successfully transferred from the SWEH1 genome from ORFs and truly new ORFs, all sequences were confirmed by BLASTx. Of the 65 ORFs, 63 indeed had annotations corresponding to a Cryptosporidium sp. (according to the NCBI nucleotide collection database), while 2 ORFs lacked a BLAST hit altogether but contained multiple InterProScan hits, indicating 1 corresponding to a possible transmembrane protein and 1 corresponding to a noncytoplasmic protein.
Variants identified in the different samples provided insight into the genomic relationship between subtypes ( Table 2 ). The ratio of all variants to nonsynonymous variants had a median of 46.5%, showing a bias toward coding region changes rather than noncoding changes. The ratio was highest in SWEH13 (IbA10G2), where 55.4% of variants caused an amino acid change, followed by SWEH11 (55.3%, IbA10G2) and SWEH9 (55.2%, IbA10G2). SWEH9 also contained the largest number of unique variants (306) among the IbA10G2 samples.
In addition, SWEH14, which is of a newly described C. hominis subtype, IkA18G1 (23), contained four times as many variants as the next most diverse sample, SWEH5 (21,296 variants versus 5,185 variants). This difference was further illustrated by looking at variants unique to a single subtype, where SWEH14 contained 20 times more unique variants than the second most unique sample, SWEH5 (13,765 variants versus 683 variants). Finally, SWEH14 contained four times as many conserved genes as any other sequenced sample in this study (data not shown). This suggests that SWEH14 has indeed diverged from the other subtypes of C. hominis on a genomic level and is a suitable candidate for an outgroup in a phylogenetic tree. Furthermore, despite being the same subtype, the IbA10G2 samples internally displayed a range of variants on both the genomic level and the amino acid level. SWEH12 in particular contained more nonsynonymous substitutions compared to the IbA10G2 reference genome than any other IbA10G2 sample, and the number of variations in general fluctuated between samples. This could be indicative of greater heterogeneity within a subtype than is usually illustrated by traditional typing methods (3, 10) .
The transition/transversion (Ti/Tv) ratios were also calculated to further investigate the genome-wide variant distribution of the subtypes (Table 3) . For SWEH1 to SWEH7 and SWEH14, this value was slightly above 3, which would be expected, as the vast majority of the genome is protein coding. In SWEH8 to SWEH12, the average values for the total ratio were ϳ1.78 and, surprisingly, ϳ1.48 in the coding regions, indicating that transversions are more common within the coding regions of IbA10G2 than in the noncoding regions. The one outlier was SWEH12, which had a Ti/Tv ratio closer to that of a non-IbA10G2 subtype.
Variants from all non-IbA10G2 subtypes causing nonsynonymous substitutions found in SWEH1 to SWEH7 (n ϭ 738) and SWEH1 to SWEH7 plus SWEH14 (n ϭ 426) were extracted and filtered against variants in SWEH8 to SWEH13 (only IbA10G2). This provided two subsets with variants causing amino acid changes present in SWEH1 to SWEH7 (n ϭ 622) or SWEH1 to SWEH7 plus SWEH14 (n ϭ 332). As IkA18G1 differed markedly from other non-IbA10G2 subtypes, in combination with the 50% reduction in nonsynonymous substitutions seen in comparing the subset with and without IkA18G1, this subset of 622 variants was then used for the single-event analysis. Selecting for gene ontologies and genes of interest then further reduced the subset. This resulted in a data set of 16 genes and 19 nonsynonymous variants. After inspection of the genes, one gene (cdg4_3550) was removed due to an inordinate number of stop codons inside the protein sequence, suggesting a nonfunctional protein. The remaining 15 genes and 18 variants were then screened using Protein Variation Effect Analyzer software (PROVEAN) to detect mutations that could potentially disrupt protein function. The results are illustrated in Table 4 .
Of the 18 amino acid mutations, 2 were predicted to be deleterious by PROVEAN (provean.jcvi.org) using a cutoff value of Ϫ1.75 (where a mutation is considered deleterious at Ϫ1.75 and a higher negative value predicts a higher deleterious effect). The mutations were found in the genes encoding Cryptosporidium oocyst wall protein 9 (COWP9; cgd6_210) and "possible apicomplexan-specific small protein" (cgd_4450). In addition, the mutation in COWP9 was a compound mutation consisting of a nonsynonymous substitution followed by a single amino acid deletion. The value corresponding to the summed impact of this compound mutation was Ϫ2.97. These mutations were then also confirmed using the Sorting Intolerant From Tolerant (SIFT [sift.bii.a-star.edu.sg]) method to confirm the predictions using a second algorithm. An alignment of the mutated site in all subtypes is illustrated in Fig. 3 .
The multiple-nonlinked-event data set was obtained by analysis of all genes containing amino acid mutations in samples SWEH1 to SWEH7 and SWEH14 followed by filtering against the mutated genes from each subtype. This resulted in a list of 604 genes with at least one amino acid mutation in SWEH1 to SWEH7 and SWEH14. This list was then filtered manually as well as by gene ontologies, resulting in a set of 28 genes of interest (Table 5 ). Nonsynonymous substitutions were analyzed using PROVEAN, and results are displayed in Table 6 . Only one gene of interest, the COWP9 gene, had deleterious mutations in all samples and, as evidenced by the single-event analysis, contained the same mutation in all of the non-IbA10G2 subtypes except IkA18G1 (Table  6) , which instead contained another deleterious mutation. However, COWP2 also showed high variability in half of the samples. Several samples also included a number of frameshift mutations, especially evident in SWEH7. These results should be treated with caution, as such mutations are a known artifact of the ION Torrent sequencing technology and any frameshift would have to be visually inspected before it could be verified. Phylogenetic analysis. In total, 743 coding sequences (CDS) were used for tree construction with 1,020 patterns in 302,083 sites. SWEH14 (IkA18G1) was chosen as an outgroup based on the number of unique variants compared to other C. hominis subtypes. The number of substitution categories was set to 4, as an increase to 8 or 12 did not improve the -log likelihood (-lnL). The optimum model was determined to be the Hasegawa-Kishino-Yama (HKY) model with an integrated gamma distribution and proportion of invariable sites (HKYϩIϩG) (with a 010010 block) and a -lnL value of 426,840.64. The final tree had a -lnL value of 426,775.84. All nodes of the tree had a bootstrap value of Ն85%, and all but two nodes had a bootstrap value of Ն95%. All IbA10G2 sequences formed a group that excluded all other subtypes (Fig. 4) .
DISCUSSION
From a public health perspective, there is a need for additional sequencing data aside from the previously published reference genomes (15, 16) in order to improve our understanding of the diversity within Cryptosporidium. This would potentially allow the relevant authorities to characterize an outbreak situation more appropriately if, for example, novel virulent genotypes have been identified. However, due to the limitations in culturing Cryptosporidium spp., it has been of paramount importance to develop strategies for obtaining as much sequencing data as possible from clinical isolates.
Here we present the genomes of 14 clinical C. hominis specimens, collected from 2013 to 2015, of which IbA10G2 was the most represented subtype and of particular interest from an outbreak perspective (5-7). As a litmus test for measuring the quality of our genome data, we performed an exploratory analysis of intra-and inter-C. hominis subtypes within our data set, including generating a new pan-IbA10G2 genome from the previous SWEH1 de novo assembly.
Using the pan-genome, we were able to analyze and explore the peculiarities of the IbA10G2 genome in comparison to those of the other sequenced subtypes on a whole-genome level.
The recently characterized IkA18G1 subtype contained a larger number of variants than the other subtypes mapped against the IbA10G2 pan-genome, corresponding well with earlier observations that IkA18G1 is more distant from the other C. hominis subtypes (23) . The IbA10G2 data set was then further explored by analysis of the ratio between synonymous and nonsynonymous substitutions, where it became evident that the IbA10G2 samples had a variable fraction of nonsynonymous substitutions ranging from 42.7% to 55.4% whereas SWEH12 had a ratio among the lowest and SWEH13 the highest in the sequenced samples. This would mean that the majority of variations found compared to the IbA10G2 pan-genome are noncoding or silent in some IbA10G2 samples whereas they are found mainly in coding regions causing nonsynonymous mutations in other cases. This merits further study, as, generally speaking, variants should accrue in areas of the genome not under selective pressure, especially in what would be closely related samples. In addition, all IbA10G2 samples had a lower transition/transversion ratio, suggesting a more even distribution of variants between coding and noncoding regions than that seen in the non-IbA10G2 samples, with the notable exception of SWEH12, which had a coding Ti/Tv ratio more in line with that seen with the non-IbA10G2 isolates. SWEH9 and SWEH12 also showed a heightened number of nonsynonymous substitutions compared to the other IbA10G2 isolates, although the number was lower than that seen with the other subspecies.
Some of the variants were also present in more than one but not all IbA10G2 isolates, which would be expected, as several samples originated from the same geographical regions. For example, 72% of the variations found in SWEH8 were also found in one or both of the two other Spanish isolates and 48% were found in SWEH9, the other Spanish isolate from 2014. Taking together all of the variants found in a Spanish isolate (1813) and removing all variants found in another IbA10G2 sample revealed 492 variants found only in the Spanish isolates. A total of 70% (836) of the variants found in the Guatemalan isolate (SWEH12) were not found in any other IbA10G2 isolate; however, 550 of those variants were found in another non-IbA10G2 C. hominis isolate. Along with the phylogenetic analysis, this is suggestive of a larger than expected heterogeneity within the IbA10G2 subtype, on the whole-genome level. In fact, we were able to identify genes containing at least one coding (silent or nonsynonymous) variant in all of the IbA10G2 isolates, as well as coding (silent or nonsynonymous) variants unique to an individual IbA10G2 isolate (see Tables S1 and S2 in the supplemental material). However, variants in all of these genes can also be found outside the IbA10G2 subtype. One cannot dismiss, however, the possibility of moreextensive heterogeneity within the other C. hominis subtypes without sequencing multiple samples of the same gp60 genotype.
After initial analysis, mutations that may be linked to parasite viability and pathogenicity were explored. We used three separate approaches in our attempt to do so. First, new putative ORFs were identified in IbA10G2 as these may contain a gene causing a gain of function. A total of 65 ORFs were identified using this method. Intriguingly, within this group, the analysis identified two ORFs which showed no similarity to any previously described gene in any Cryptosporidium species. However, the true nature of these proteins is difficult to ascertain as there is only limited information available from BLAST and gene ontology, which may warrant further study. Second, sites containing conserved events causing an amino acid change were identified in all non-IbA10G2 species. This would be the case when a single event causes a mutation, dividing C. hominis between the IbA10G2 and non-IbA10G2 subtypes. Here, IkA18G1 was removed from the analysis due to the novel status of the Ik subtype family (23, 24) . The original variant data set contained 622 variants not present in IbA10G2. Genes of interest that were broadly selected using the following criteria were as follows: (i) genes linked to oocyst formation and function in previous studies such as the COWP family genes (cgd7_1800, cgd6_200, and cgd6_210), which are believed to play a fundamental role in the durability of oocysts (25) , and the CpCCP1 gene (cgd_1730), which is actively expressed at the sporozoite stage of development and yet may play a role in parasitophorous vacuole integrity (26, 27) , and (ii) genes with a Gene Ontology classification suggestive of being involved in cell homeostasis, development, or invasion, such as the TRAP-C2 gene (cgd5_3420), encoding a member of the thrombospondin-related anonymous protein family, linked to apicomplexan cell invasion (28) . The full list of genes is shown in Table 4 . One gene, the COWP9 gene (cgd6_210), encoded a deleterious amino acid mutation confirmed by both PROVEAN and SIFT, suggesting a nonfunctional protein modification.
Finally, several nonlinked events were explored by extracting all genes containing a nonsynonymous substitution anywhere in the coding region. This data set contained 604 genes and was filtered similarly to the single-event analysis. Here it became evident that SWEH14 also contained a deleterious mutation in the COWP9 gene, making it the only gene to have a deleterious mutation in all subtypes except IbA10G2 as confirmed by two independent algorithms (SIFT and PROVEAN).
In recent years, several laboratories have published a number of strategies for the purification and enrichment of Cryptosporidium oocysts from fecal specimens, using filtration and salt flotation, as well as such methods as amplification of extracted DNA (19) (20) (21) . The current study, using clinical C. hominis samples, confirms the proof-ofprinciple method previously published by our group (18) as an effective pipeline for processing Cryptosporidium species patient samples for genome sequencing. In contrast to other methods, our protocol involves two unique steps (18) . During the purification and enrichment process, we enrich the oocysts directly using the modified IMS protocol. This minimizes the number of purification steps and thereby minimizes potential loss of target material. In addition, we removed sufficient levels of contaminants to proceed to the NGS platform (Table 1 ) without needing to sterilize the oocysts. The second crucial difference is the PCR amplification of the 400-bp Ion Xpress fragment target library, performed to obtain sufficient DNA to apply to the massive parallel-sequencing platform-a necessity due to the limited number of oocysts and target DNAs found in most clinical specimens. An additional benefit is that such an amplification method minimizes the potential for amplification GC bias, which can be generated from multiple displacement amplification (MDA) and, to a lesser extent, from multiple annealing and looping-based amplification cycles (MALBAC) kits (29, 30) .
Most C. hominis infections and outbreaks in the industrialized world are linked to IbA10G2 (3, 7) , and characterization of the functional role that the unique IbA10G2 variants play in the development, dissemination, and virulence of this subtype warrants further investigation. It would be of great interest to determine whether such amino acid substitutions have an effect on the biology of the Cryptosporidium parasite. Recent breakthroughs in the ability to genetically manipulate (31) or continuously culture (32) Cryptosporidium should provide a platform for more direct functional studies on both reference and clinical Cryptosporidium species samples.
Previously published work suggests that the population structure of different Cryptosporidium species is more complex than initially considered (7-9, 33, 34) . A number of different multilocus panels have been tested, demonstrating the existence of sufficient sequence variance between species and within subtypes, pertaining to the identification and use of novel genome targets for epidemiological investigation (10, 35, 36) . However, the vast majority of such studies compare data between limited numbers of genomes, which makes the task of identifying new markers even more problematic. Cryptosporidium genomes are being sequenced at a pace (17) (18) (19) (20) (21) 37 ) that is increasing our general knowledge of Cryptosporidium spp. Subsequent sequencing of additional genomes, especially from clinical samples, will increase the likelihood of facilitating the identification of new genetic markers in order to improve the classification of species status, as well as increasing the genotyping resolution of C. parvum and C. hominis subtype population genetics and epidemiology. The dramatic increase in the amount of genomic data being published will increase the likelihood of designing and applying an alternative genotyping method which better encompasses the likely genetic divergence of Cryptosporidium spp., in order to complement or improve upon the current genotyping methods (2) . Ultimately, such a panel or library would facilitate the implementation and transfer of Cryptosporidium genotyping to NGS platforms, as has been demonstrated for other pathogens (14) .
In summary, here we describe the genetic diversity revealed in 14 clinical C. hominis isolates by using genome sequencing. We have focused our efforts on C. hominis IbA10G2 and have identified several features unique to this subtype. We believe that the data generated from the current and future genome sequencing studies, using C. parvum and C. hominis, as well as rarer clinical Cryptosporidium species, will provide a platform for the future functional and comparative genomic analysis of Cryptosporidium, with the aim of improving public health outbreak analyses.
MATERIALS AND METHODS
Species determination and subtyping. Between the years 2012 and 2014, the Swedish Institute for Communicable Disease Control (now known as the Public Health Agency of Sweden) carried out a project to determine the Cryptosporidium population structure in Swedish patients (unpublished data). Clinical samples, collected from the aforementioned project, were used in the current study and filed under designations SWEH1 to SWEH14 (see Table 1 ). Approval was obtained from the Ethical Review Board at Karolinska Institutet, Stockholm, Sweden.
Disruption of oocysts was performed directly with unfixed stool specimens by bead beating using a Bullet Blender (Techtum, Sweden), followed by DNA extraction performed using a QIAamp DNA minikit (Qiagen, Germany) according to the manufacturer's recommendations. Species identification was performed by amplification of the small-subunit rRNA (SSU rRNA) gene followed by restriction fragment length polymorphism analysis (38, 39) . Subtyping was achieved by sequencing an amplified fragment of the gp60 gene (22) . Sequences were edited and analyzed using CLC Main Workbench (Qiagen, Aarhus, Denmark, version 6.9.1) and the BioEdit sequence alignment editor (version 7.0.9.0). The obtained sequences were aligned with each other and compared with sequences downloaded from the GenBank database using the NCBI BLAST searching tool (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi).
Genome sequencing-sample purification and DNA preparation. Genomic DNA from 14 clinical C. hominis stool samples (SWEH1 to SWEH14; Table 1 ) was extracted following oocyst purification and enrichment using our adapted protocol as described previously (18) . To briefly summarize, approximately 1 g from each sample was purified using target-specific immunomagnetic separation (IMS) (Dynabeads anti-Cryptosporidium; Thermo Fisher, USA). The levels of purity and enrichment were assessed by analyzing 5 l of each preparation prior to and after IMS using Crypto Cel fluorescent staining (Cellabs, Australia; Nikon Eclipse E400, Japan). In some cases, the IMS procedure had to be repeated once or twice until no detectable background contamination could be observed. Then, samples were extracted using a QIAamp DNA minikit. The concentration of DNA in the extracted samples was determined using Qubit fluorometric quantification (Thermo Fisher) according to the manufacturer's instructions.
Genome sequencing-whole-genome amplification and massive parallel sequencing. Due to the low levels of detectable DNA present after extraction, we used a strategy to amplify the library in order to obtain sufficient material for whole-genome sequencing (18) . Briefly, a library for each sample was created by fragmenting the DNA and adding adaptors to the ends, using an Ion Xpress Plus fragment library kit for an AB Library Builder system (Thermo Fisher) according to the manufacturer's autoshearing program for a 400-bp library without size selection. Then, following a critical amplification step added to the standard protocol, the library was size selected (ss) using Pippin Prep (Sage Science, USA) and purified using AMPure beads (Beckman Coulter, USA). The ss libraries were clonally amplified using an Ion Chef system and an Ion One Touch 2 system (Thermo Fisher), respectively, and then used for whole-genome sequencing on an Ion Torrent Personal Genome Machine (PGM) using an Ion PGM IC 200/400 kit and an Hi-Q sequencing kit, respectively (Thermo Fisher).
Sequence annotation. Our IbA9G3 C. hominis reference genome (SWEH1/ Table 1 ) was sequenced to an average coverage of 490ϫ and annotated in several steps (18) . Briefly, existing annotations were transferred from the C. parvum Iowa II genome using BLASTn (settings) in a CLC genome finishing module (Qiagen). Putative new ORFs were then identified using CLC Genomics Workbench v8.5 (Qiagen). Gene sequences representing the new ORFs and transferred annotations were then extracted and imported into BLAST2GO for gene ontology annotation using the standard BLAST2GO pipeline.
Mapping and variant analysis. NGS data were analyzed using the CLC Genomics Workbench. First, a pan-IbA10G2 genome was obtained by mapping all reads from IbA10G2 samples to the SWEH1 reference genome after a standard quality trim (default value, 0.05; maximum of 2 ambiguous bases) using the CLC genomics workbench mapper. Indels were detected using the Indels and Structural Variant tool (maximum of 3 mismatches, minimum of 2 supporting reads) and used for three rounds of local realignment. The consensus sequence for IbA10G2 was then extracted, conflicts were resolved by voting, and gaps were filled using the SWEH1 genome sequence.
Individual samples were then trimmed and mapped and indels called using 3 mismatches, a minimum of 4 supporting reads, and a P value of 10 Ϫ4 followed by three rounds of local realignment. Variants were called on the locally realigned mapping using the low-frequency variant caller with a minimum coverage of 5, a count of 3, and a minimum frequency of 15%. The variants were then filtered according to an average base quality value of Ͼ20, a neighborhood quality value of Ͼ15 in a neighborhood size of 5, a QUAL value of Ͼ100, and a read position and read direction probability of Ͼ0.7. Homopolymer errors introduced by the Ion Torrent sequencing technology were accounted for by filtering variants with a frequency of Ͻ80% in homopolymer regions of 3 or longer. Variants causing nonsynonymous amino acid changes, and the corresponding number of genes, were then extracted from the total variant data set for each sample (Table 2 ). In addition, variants unique to each sample, unique nonsynonymous variants, and the corresponding genes were also identified using the CLC Genomics Workbench by joint evaluation of the variants and read mappings. Finally, genes containing a nonsynonymous mutation found in only a single subtype were identified ( Table 2 ).
The variant populations were then internally compared and variants identified and grouped within SWEH1 to SWEH7 (non-IbA10G2 subtypes, excluding IkA18G1), and SWEH1 to SWEH7 and SWEH14 (non-IbA10G2 subtypes) were extracted and filtered against variants common to the IbA10G2 subtype by read mapping subtraction. The variant data sets were then reduced by identifying genes of interest either from the gene annotation or the gene ontology. Variants in genes of interest were then further screened using PROVEAN (provean.jcvi.org) with the default settings and SIFT (http://sift.bii.a-star.edu.sg) with a median value of 3, a UniRef value of 90, and 95% identity to determine the impact of the variants on protein folding.
Tree construction. Gene sequence information was extracted from whole-genome mappings using CLC Genomics Workbench. Genes with no coverage in one or more samples were pruned from the data set using a Perl script whereby coding sequences (CDS) containing more than 2% unknown bases compared to the C. hominis TU502 reference genome version (ASM642v2) were removed. All unknown bases were then removed from the remaining subset, and CDS were individually aligned using Clustal Omega 1.2.0 with mbed and 4 hidden Markov model (HMM) iterations of realignment. The CDS alignments were then concatenated using a Perl script, and the final alignment was used for tree construction. The tree was constructed in PhyML3.1 with a Hasegawa-Kishino-Yama (HKY) model with an integrated gamma distribution and proportion of invariable sites (HKYϩIϩG) substitution (010010 block) while optimizing tree, branch length, and rate parameter, SPR (Subtree Pruning and Regrafting) traversal, free rates, 5 random starting trees, 4 substitution categories, and 300 bootstrap replicates (40) . The model was obtained by evaluating all possible substitution models (n ϭ 1,624) using the application jModeltest2 (SPR; 203 substitution schemes; Bayesian information criterion [BIC] clustering; 4, 8, and 12 substitution categories; proportion-invariable sites; unequal base frequencies) and selected using the negative log likelihood of the three available information criteria (Akaike, Bayesian, and decision theory) (41) . Accession number(s). Raw sequencing data for the 14 C. hominis genomes (SWEH1 to SWEH14) are available in the NCBI Short Read Archive (SRA), accessible through the BioProject with accession number PRJNA307563. Additionally, the assembled genome sequence of SWEH1 (IbA9G3) is available under the same BioProject accession number.
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